Group 1 - The company, Redick, responded to investor inquiries on January 9, indicating that specific information regarding Northern Machinery products should be monitored through publicly disclosed information [2]

Group 1 - The company indirectly holds a 20% stake in Qishan Northern Machinery Co., Ltd. [2] - Investors are encouraged to pay attention to the publicly disclosed information regarding Northern Machinery's products. [2]

Group 1 - The company, 雷迪克, confirmed that it will disclose the number of shareholders in each periodic report as required by the Shenzhen Stock Exchange [1] - For inquiries regarding the number of shareholders outside of the periodic reports, the company requests that relevant proof of shareholding, identity information, and contact details be sent to the company's securities department email for further inquiry [1] - The company's production and operational situation is currently normal [1]

Group 1 - The brain-computer interface sector in the A-share market experienced a significant decline, with multiple companies reporting substantial drops in their stock prices [1] - Major companies such as Mailland, Chengyitong, and Aipeng Medical saw declines exceeding 10%, while others like Leidi Ke and Weisi Medical dropped over 8% [1][2] - Several brain-computer interface concept stocks issued announcements indicating a cooling off, with companies like Aerospace Changfeng stating they have not actually engaged in related business activities [1] Group 2 - Mailland's stock fell by 11.09%, with a total market value of 54.43 billion [2] - Chengyitong's stock decreased by 10.91%, with a market capitalization of 6.731 billion [2] - Aipeng Medical's stock dropped by 10.39%, with a market value of 4.514 billion [2]

Core Viewpoint - The A-share market has seen a significant pullback in several brain-computer interface (BCI) concept stocks, with notable declines among various companies [1] Group 1: Stock Performance - Companies such as 麦澜德 (Mikland) and 熵基科技 (Entropy Technology) experienced declines exceeding 10% [1] - 诚益通 (Chengyi Tong) and 雷迪克 (Redik) fell over 7% [1] - 博拓生物 (Botuo Bio) and 爱朋医疗 (Aipeng Medical) dropped more than 6% [1] - 可孚医疗 (Kefu Medical) and 翔宇医疗 (Xiangyu Medical) decreased over 5% [1] - 狄耐克 (Dinaike) and 伟思医疗 (Weisi Medical) saw declines greater than 4% [1] Group 2: Company Announcements - Multiple BCI concept stocks issued announcements indicating a cooling off in the market [1] - 航天长峰 (Aerospace Changfeng) stated that the company has not actually engaged in BCI-related business [1] - 伟思医疗 (Weisi Medical) mentioned that new products in the BCI field are still in the early stages of market cultivation [1]

Group 1 - The A-share market has seen a significant pullback in brain-computer interface (BCI) concept stocks, with notable declines in companies such as Mailland and Entropy Technology, which fell over 10% [1] - Several BCI concept stocks have issued announcements indicating a cooling off, with Aerospace Changfeng stating that it has not actually engaged in BCI-related business [1] - Weisi Medical mentioned that its new products in the BCI field are still in the early stages of market cultivation [1] Group 2 - Specific stock performance includes Mailland down 10.68% with a market cap of 5.468 billion, Entropy Technology down 10.13% with a market cap of 10.1 billion, and Chengyi Tong down 7.55% with a market cap of 6.985 billion [2] - Other notable declines include Leedick down 7.14%, Botao Biological down 6.37%, and Aipeng Medical down 6.38% [2] - The overall trend shows that many BCI-related stocks are experiencing a downturn, with declines ranging from 4.33% to 10.68% across various companies [2]

Group 1 - The core point of the article is that Redick announced a reduction in shareholding by its controlling shareholder, Tianyi No. 1, through block trading [1] - The reduction involved 2.66 million shares, which represents 1.99% of the total share capital [1] - Following the reduction, the shareholding percentage decreased from 8.95% to 6.96% [1]

Core Viewpoint - The company, Redick (300652.SZ), has completed a share reduction plan executed by Tianyi No. 1, which involved a total reduction of 2.66 million shares, accounting for 1.99% of the company's total share capital [1] Summary by Categories - **Share Reduction Details** - Tianyi No. 1 reduced its holdings by 2.66 million shares from December 30, 2025, to January 6, 2026 [1] - The reduction represents 1.99% of the total share capital of the company [1] - **Completion of the Plan** - As of the date of the announcement, the share reduction plan has been fully implemented [1]

2025 年 12 月 30 日至 2025 年 12 月 31 日期间，添益 1 号以大宗交易方式减 持公司股份合计 201 万股，约占公司总股本比例 1.51%，权益变动触及 1%整数倍。 公司在巨潮资讯网（http://www.cninfo.com.cn）披露了《关于持股 5%以上股 东减持股份触及 1%整数倍的公告》（公告编号：2025-087）。 近日，公司收到添益 1 号出具的《股份减持计划实施完成的告知函》，添益 1 号在 2025 年 12 月 30 日至 2026 年 1 月 6 日期间，通过集中大宗交易方式合计 减持公司股份 266 万股（占公司总股本的 1.99%）。截至本公告披露日，添益 1 号本次减持计划已实施完毕。 证券代码：300652 证券简称：雷迪克 公告编号：2026-001 杭州雷迪克节能科技股份有限公司 关于持股 5%以上的股东减持计划实施完成的公告 公司持股 5%以上的股东日照中益仁私募基金管理有限公司－中益仁添益 1 号 私募证券投资基金保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义 ...

Core Viewpoint - The trading volume of Redick reached a new high since its listing, indicating strong market interest and investor confidence in the stock [2] Group 1: Trading Performance - As of 10:18, Redick's trading volume was 1.078 billion yuan, marking a record high since its IPO [2] - The latest stock price increased by 9.80%, reflecting positive market sentiment [2] - The turnover rate was reported at 12.71%, suggesting active trading activity among investors [2] Group 2: Comparison with Previous Trading Day - The trading volume on the previous trading day was 974 million yuan, highlighting a significant increase in trading activity [2]